Oncogenic miR-17/20a Forms a Positive Feed-forward Loop with the p53 Kinase DAPK3 to Promote Tumorigenesis

Area of Science:

• Molecular Biology
• Oncology
• Gene Regulation

Background:

• MicroRNAs (miRs) are regulatory RNAs involved in various biological processes, including cancer.
• miR-17/20a, an oncomiR, targets E2F family members, forming a feedback loop for cell cycle control.
• The known pathway is insufficient to explain high oncomiR levels in cancer.

Purpose of the Study:

• To identify novel mechanisms regulating miR-17/20a expression in cancer.
• To elucidate the role of DAPK3 in the miR-17/20a oncogenic pathway.
• To understand how this pathway contributes to tumorigenesis and genome instability.

Main Methods:

• Investigated the interaction between miR-17/20a and DAPK3.
• Utilized cell-based assays to study p53-dependent transcriptional regulation.
• Assessed the impact of DAPK3 on genome instability and tumor formation in vivo.

Main Results:

• miR-17/20a directly targets and inhibits DAPK3, a p53 activating kinase.
• DAPK3 inhibition leads to p53-dependent de-repression of miR-17/20a.
• DAPK3 is essential for preventing miR-17/20a depletion-induced genome instability.
• Overexpression of miR-17/20a, mediated by DAPK3 targeting, promotes tumor formation.

Conclusions:

• A novel tumorigenic pathway involving miR-17/20a and DAPK3 has been identified.
• This pathway contributes to miR-17/20a amplification and tumor growth in various human cancers.
• Targeting this pathway could offer new therapeutic strategies for cancer treatment.